The master genes BMAL1 and CLOCK are both essential for the survival of glioblastoma CSCs, so the researchers developed a Cry activator, SHP1705, which helps inhibit BMAL1 and CLOCK transcriptional activity. The gene discussed is CRYL1; the disease is glioblastoma.